Oxazepam

5 trials 3 recruiting NNeurology/Psychiatry

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

3 Recruiting

2 Completed trials

4 Sponsors

4 Countries

Phase III

Phase II

Other

Phase III: 1 Phase II: 2 Other: 2

Indications tested

Anxiety 2 Delirium tremens 2

Sponsors using this IMP

Laboratorios Lesvi S.L. 2 Amsterdam UMC 1 Helse Bergen HF 1 Region Hovedstadens Psykiatriske 1

All trials

5 total

Acute Effects of Partial GABA(A)-Receptor Modulation by GT-002 on Psychophysiological Measures: The TOTEMS Phase II Clinical Trial Targeting… Recruiting

2024-519389-28-00 Phase II 1 country Region Hovedstadens Psykiatriske
Soothing Pain After ChEmotherapy: Psilocybin As INtervention (SPACE-PAIN) — a randomized controlled pilot trial Recruiting

2024-516936-93-02 Phase II 1 country Amsterdam UMC
Benzodiazepine stabilizing treatment for patients with benzodiazepine dependence undergoing opioid agonist therapy (BMX-BAR) Recruiting

2023-510404-44-02 Phase III 1 country Helse Bergen HF
Bioequivalence of Oxazepam 50 mg Orodispersible Tablets Versus Seresta® 50 mg Tablets in Healthy Subjects. Ended

2022-501135-16-00 1 country Laboratorios Lesvi S.L.
Bioequivalence of Oxazepam 10 mg Orodispersible Tablets Versus Seresta® 10 mg Tablets in Healthy Subjects Ended

2022-501134-35-00 1 country Laboratorios Lesvi S.L.

Showing 1–5 of 5 trials

← All drugs A–Z